Graves 病复发影响因素研究进展
摘要
本文通过对近年来国内外研究文献的分析，对 Graves 病复发的影响因素进行了综述，并对该领域的最新研究进展进行讨论。
关键词
全文:
PDF参考
[1]Le Moli R, Malandrino P, Russo M, et al. Corticosteroid
Pulse Therapy for Graves’ Ophthalmopathy Reduces the
Relapse Rate of Graves’ Hyperthyroidism[J]. Front Endocrinol
（Lausanne）, 2020,11:367.
[2] Chung J H. Antithyroid Drug Treatment in Graves’
Disease[J]. Endocrinol Metab （Seoul）, 2021,36（3）:491-499.
[3] 中华医学会内分泌学分会中国甲状腺疾病诊治指
南编写组 . 中国甲状腺疾病诊治指南——甲状腺功能亢进症
[J]. 中华内科杂志 , 2007,46（10）:876-882.
[4] Jiang X, Hu H, Fu Z, et al. ASSOCIATION BETWEEN
THE CTLA-4 EXON 1+49A/G POLYMORPHISM AND
THE RELAPSE OF GRAVE’S DISEASE AFTER ATD
WITHDRAWAL: A META-ANALYSIS[J]. Acta Endocrinol
（Buchar）, 2022,18（3）:324-332.
[5] Yao Q, Song Z, Wang B, et al. Identification of lncRNA
and mRNA Expression Profile in Relapsed Graves’ Disease[J].
Front Cell Dev Biol, 2021,9:756560.
[6] 王月桂 , 洪理伟 , 吕国荣 , 等 . 超声联合 Ki67 分析
Graves 病患者 131I 治疗后甲亢未愈或复发的相关因素 [J]. 南
方医科大学学报 , 2022,42（12）:1902-1906.
[7] Benvenga S, Elia G, Ragusa F, et al. Endocrine
disruptors and thyroid autoimmunity[J]. Best Pract Res Clin
Endocrinol Metab, 2020,34（1）:101377.
[8] Chen D W, Yeh M W. Disparities in Thyroid Care[J].
Endocrinol Metab Clin North Am, 2022,51（2）:229-241.
[9] 王卫民 . 积极心理干预对甲状腺功能亢进患者
焦虑、抑郁情绪的影响 [J]. 中国健康心理学杂志 , 2020,28
（01）:83-86.
[10] Vaivode I, Zake T, Strele I, et al. Stress-Related
Immune Response and Selenium Status in Autoimmune Thyroid
Disease Patients[J]. Int J Mol Sci, 2023,24（3）.
[11] 李利利 . 压力管理方案对抑郁症患者病情控制、应
对方式的影响 [J]. 罕少疾病杂志 , 2021,28（01）:81-83.
[12] 吴秀平 , 黄清云 . 甲状腺功能亢进症患者自我效
能感与用药依从性的调查分析 [J]. 中国医药科学 , 2022,12
（14）:110-113.
[13] Gorini F, Sabatino L, Pingitore A, et al. Selenium: An
Element of Life Essential for Thyroid Function[J]. Molecules,
2021,26（23）.
[14] Cho Y Y, Chung Y J. Vitamin D supplementation
does not prevent the recurrence of Graves’ disease[J]. Sci Rep,
2020,10（1）:16.
[15] 夏秦 . 儿童 Graves 病的血清非靶向代谢组学研究
[D]. 苏州大学 , 2021.
[16] Bostan H, Ucan B, Kizilgul M, et al. Relapsed and
newly diagnosed Graves’ disease due to immunization against
COVID-19: A case series and review of the literature[J]. J
Autoimmun, 2022,128:102809.
[17] Cao J, Wang N, Luo Y, et al. A cause-effect relationship
between Graves’ disease and the gut microbiome contributes
to the thyroid-gut axis: A bidirectional two-sample Mendelian
randomization study[J]. Front Immunol, 2023,14:977587.
(10 摘要 Views, 33 PDF Downloads)
Refbacks
- 当前没有refback。